Mode
Text Size
Log in / Sign up

MCID for AOFAS Ankle Hindfoot Scale estimated at 4.1 to 7.8 points after ankle fracture surgery

MCID for AOFAS Ankle Hindfoot Scale estimated at 4.1 to 7.8 points after ankle fracture surgery
Photo by Cht Gsml / Unsplash
Key Takeaway
Consider AOFAS score changes of 4.1-7.8 points as potentially clinically relevant after ankle fracture surgery.

This multicenter randomized controlled trial aimed to determine the minimal clinically important difference (MCID) for the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle Hindfoot Scale. The study enrolled 148 patients with surgically treated unstable ankle fractures and followed them for 12 months. Median AOFAS scores improved significantly from 73.0 at 3 months to 85.0 at 12 months postoperatively (p < 0.001).

The primary outcome was the MCID for the AOFAS score, calculated using multiple methods. Anchor-based methods produced MCID estimates of 7.1 for the 3- to 6-month interval and 7.8 for the 6- to 12-month interval using the mean change method, and 0.5 and 5.5 for the same intervals using ROC curve analysis. Distribution-based methods yielded estimates of 9.2 at 3 months, 8.2 at 6 months, and 7.1 at 12 months. The minimal detectable change (MDC) was 3.5 at 3 months, 2.8 at 6 months, and 4.1 at 12 months.

Safety and tolerability data were not reported. Key limitations include the inherent uncertainty in MCID estimation, as different calculation methods produced varying results. The study did not evaluate a specific surgical or rehabilitation intervention. The practice relevance is that a change in AOFAS score between 4.1 and 7.8 points may be considered clinically relevant at the 1-year follow-up, but clinicians should recognize the methodological variability in these estimates.

Study Details

Study typeRct
Sample sizen = 148
EvidenceLevel 2
Follow-up12.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUD: The American Orthopaedic Foot and Ankle Society (AOFAS) Ankle Hindfoot Scale is frequently used as a patient-reported outcome measure (PROM) to evaluate recovery trajectories following foot and ankle injuries. This study aimed to determine the minimal clinically important difference (MCID) for the AOFAS score in patients with surgically treated unstable ankle fractures. METHODS: Data were obtained from the ROutine versus on DEmand removal Of the syndesmotic stabilisation screw (RODEO) trial, a multicenter randomized controlled trial evaluating the management of syndesmotic screw fixation following ankle fracture surgery. Eligible patients completed the AOFAS scale at 3, 6, and 12 months postoperatively. The MCID was calculated using both anchor-based approaches (mean change, receiver operating characteristic [ROC] analysis) and distribution-based approaches (minimal detectable change [MDC] and 0.5 standard deviation). RESULTS: A total of 148 patients were included, with a mean age of 47 years, and a male predominance of 63.5%. Median AOFAS scores improved significantly over time, rising from 73.0 at 3 months to 85.0 at 12 months postoperatively ( < 0.001). The MCID for the anchor-based mean change method was calculated to be 7.1 for the 3- to 6-month interval and 7.8 for the 6- to 12-month interval. ROC curve analysis indicated MCID values of 0.5 and 5.5 for these intervals, respectively. Distribution-based MCIDs were 9.2 at 3 months, 8.2 at 6 months, and 7.1 at 12 months. The MDC was 3.5 at 3 months, 2.8 at 6 months, and 4.1 at 12 months. CONCLUSIONS: Despite the extended recovery period, often up to 12 months, following surgical stabilization of unstable ankle fractures with syndesmotic injury, the AOFAS remains one of the most utilized PROMs in this context. Based on these findings, a change in score between 4.1 and 7.8 points should be considered clinically relevant at the 1-year follow-up.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.